Vanberra Signal

12-15 Molecular Diagnostics

Curated by Signal

Developer of nanotech based molecular diagnostics

Overview

Mysite01 offers molecular diagnostic POC devices. The point of care device is used to detect bacterial and viral infections in veterinary applications such as pets and farm animals. The samples are collected and tested where the results are analyzed using AI-based algorithms to provide the test reports. Some of the partners are the University of New Haven, University of Connecticut, PRESCO, and ctnext.

Key facts

Founded
2016

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Digital pathological data management tool for providers

    Health TechnologyUnited States
  • Provider of technical infrastructure to train and pay family caregivers

    Health TechnologySan Francisco, United States
  • Provider of business management software for pharmacies and hospitals

    Health TechnologyDublin, United States

About 12-15 Molecular Diagnostics

What does 12-15 Molecular Diagnostics do?

Mysite01 offers molecular diagnostic POC devices.

Where is 12-15 Molecular Diagnostics headquartered?

12-15 Molecular Diagnostics is headquartered in Branford, United States.

When was 12-15 Molecular Diagnostics founded?

12-15 Molecular Diagnostics was founded in 2016.

Which sector is 12-15 Molecular Diagnostics in?

12-15 Molecular Diagnostics operates in Health Technology.

Who are 12-15 Molecular Diagnostics's competitors?

Companies similar to 12-15 Molecular Diagnostics include Histofi, Oma Care, and CPS Solutions.